Cited 0 times in Scipus Cited Count

Prognostic Factors of Nasal NK/T Cell Lymphoma

Other Title
비부비동에 발생한 NK/T 세포 림프종의 예후인자 분석
Authors
김, 동현 | 윤, 주헌 | 김, 현준  | 강, 희선 | 박, 정섭 | 강, 성욱  | 홍, 성표
Citation
Journal of the Korean Otolaryngological Society, 50(1). : 37-42, 2007
Journal Title
Journal of the Korean Otolaryngological Society
ISSN
1225-035X
Abstract
Background and Objectives : Nasal natural killer T (NK/T) cell lymphomas are relatively common in Asia, but the prognostic factors are not well known. The purpose of this research was therefore to evaluate those prognostic factors.



Subjects and Method : We reviewed and analyzed the medical records of 68 patients diagnosed as nasal NK/T cell lymphomas between 1984 and 2003 at Ajou University Hospital and at Yonsei University Hospital. Prognostic factors that include age, B symptoms, serum lactate dehydrogenase (LDH) levels, Eastern cooperative oncology group (ECOG) performance status, international prognostic indices (IPI), treatment modality, and Ann Arbor tumor stages were analyzed using the methods of univariate and multivariate statistics.



Results : The five-year overall survival rate was 43%. By univariate analysis, we found ECOG performance status, Ann Arbor tumor stages, B symptoms, and IPI to be significant prognostic factors of nasal NK/T cell lymphoma. The multivariate analysis showed that ECOG performance status and B symptoms were significant.



Conclusion : ECOG performance status, Ann Arbor tumor stages, B symptoms, and IPI could all be prognostic factors of the nasal NK/T cell lymphoma. Among these factors, ECOG performance status and B symptoms may be regarded more useful in diagnosis of the disease than others.
Keywords

Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Otolaryngology
Ajou Authors
강, 성욱  |  김, 현준
Files in This Item:
Journal of the Korean Otolaryngological Society_50(1)_37-42.pdfDownload
Export

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse